Costs of bronchoalveolar lavage-directed therapy in the first 5 years of life for children with cystic fibrosis.
Data(s) |
01/09/2014
|
---|---|
Resumo |
To determine whether bronchoalveolar lavage (BAL)-directed therapy for infants and young children with cystic fibrosis (CF), rather than standard therapy, was justified on the grounds of a decrease in average costs and whether the use of BAL reduced treatment costs associated with hospital admissions. |
Identificador | |
Idioma(s) |
eng |
Publicador |
Elsevier |
Relação |
http://dro.deakin.edu.au/eserv/DU:30070086/moodie-costofbronchoalveolar-2014.pdf http://www.dx.doi.org/10.1016/j.jpeds.2014.05.031 http://www.ncbi.nlm.nih.gov/pubmed/24996984 |
Direitos |
2014, Elsevier |
Palavras-Chave | #Australasian Cystic Fibrosis Bronchoalveolar Lavage Study Investigators #Science & Technology #Life Sciences & Biomedicine #Pediatrics #YOUNG-CHILDREN #INFECTION #INFANTS #STATE #CARE #Bronchoalveolar Lavage #Child, Preschool #Costs and Cost Analysis #Cystic Fibrosis #Humans #Infant #Patient Admission |
Tipo |
Journal Article |